Pharmaceutical fresh frozen plasma
Phase 3Biologic
Pharmaceutical fresh frozen plasma is one of 36 biologic programs targeting Sepsis. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
35
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
100 competitors in Sepsis
#DrugCompanyPhaseTrials
1Dobutrex
PfizerPhase 2
Proamatine
TakedaPhase 2
Antibiotics
MMelinta Therapeutics, Inc.
Phase 3
N-Acetylcysteine (NAC) Treatment
TThe First Affiliated Hospital of Soochow University
Phase 3
G-CSF
AArog Pharmaceuticals, Inc.
Phase 2
Nafamostat Mesylate
EEnsysce Biosciences
Phase 3
Pharmaceutical fresh frozen plasma
FFundación Cardioinfantil Instituto de Cardiología
Phase 3
Hydrocortisone Administration
UUniversity of Virginia
Phase 3
Simdax
Orion Corporation, Orion PharmaPreclinical
Zyvox
PfizerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sepsis1 trial
Randomized Control Study in REsuscitation of SEpsis Trial
Not yet recruiting·FFundación Cardioinfantil Instituto de Cardiología·Phase 4·NCT07035509·150 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details